Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study
BMC PULMONARY MEDICINE（2021）
摘要
An amendment to this paper has been published and can be accessed via the original article.
更多查看译文
关键词
Nintedanib, Krebs von den Lungen-6, Surfactant protein A, Diffusion capacity for carbon monoxide, Acute exacerbation, Mortality
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要